TMCnet News

Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

[July 04, 2014]

Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/22vwnt/pharmasphere) has announced the addition of the "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market" report to their offering.

Our report, "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market", provides strategic analysis of the global biosimilars industry. It discusses key market trends, regulatory requirements in various markets, recent deals activity and trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as India - providing in-depth analysis of these markets' regulatory framework, key domestic players and their biosimilar pipelines, and strategic outlook

Key Questions Answered

What are the drivers of the global biosimilars industry?
Who are the top players involved in the development of biosimilars in the developed markets of Europe and the US, as well as in emerging markets, including India and China?
What are the major barriers to entry into the biosimilars industry?
What specific strategies are companies utilizing to combat some of the challenges currently facing the development of the global biosimilars industry?
What is the current state of biosimilars regulation in the EU, US, Japan, India, China, and South Korea?

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Market Overview

4 Biosimilar Deals Trends

5 Biosimilars Regulation

6 Biosimilars in the US

7 Biosimilars in Europe

8 Biosimilars in Japan

9 Biosimilars in India

10 Biosimilars in South Korea

11 Biosimilars in China